These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
Their benefits are most noticeable in people who have low or borderline B12 levels, absorption challenges, or increased needs
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Vascular Recruitment and Gastrointestinal Tract Healing Curr Pharm Des, 24 (18) (2018), pp
Thus, the counteracting effect of BPC 157 therapy should comprise the primary mechanism of action
Most users report minimal side effects